Witaya Sungkarat

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Sickle Cell Disease

Iron Deficiency

Top Venues

Pharmaceutical development and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Ampaiwan Chuansumrit, Duantida Songdej, Nongnuch Sirachainan, Praguywan Kadegasem, Pawaree Saisawat, Witaya Sungkarat, Ketsuda Kempka, Noppawan Tangbubpha
Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload. Hemoglobin 48 (1) (2024)
Ampaiwan Chuansumrit, Duantida Songdej, Nongnuch Sirachainan, Praguywan Kadegasem, Pawaree Saisawat, Witaya Sungkarat, Ketsuda Kempka, Noppawan Tangbubpha
Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload. Hemoglobin 48 (1) (2024)
Ampaiwan Chuansumrit, Duantida Songdej, Nongnuch Sirachainan, Praguywan Kadegasem, Pawaree Saisawat, Witaya Sungkarat, Ketsuda Kempka, Noppawan Tangbubpha
Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload. Hemoglobin (2024)
Anisha Mazumder, Anupma Dwivedi, Wirat Assawapanumat, Rungnapha Saeeng, Witaya Sungkarat, Norased Nasongkla
In vitro galactose-targeted study of RSPP050-loaded micelles against liver hepatocellular carcinoma. Pharmaceutical development and technology 27 (4) (2022)
Nussana Thitichai, Chalaisorn Thanapongpibul, Norased Nasongkla, Witaya Sungkarat, Norased Nasongkla
Study of biodistribution and systemic toxicity of glucose functionalized SPIO/DOX micelles. Pharmaceutical development and technology 24 (8) (2019)